Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 143

Results For "MP"

10743 News Found

Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
Clinical Trials | May 26, 2026

Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy

A one-shot gene-editing cholesterol therapy could soon be a reality


International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth
News | May 26, 2026

International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth

Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023


China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer
Drug Approval | May 26, 2026

China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer

The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer


Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors
News | May 25, 2026

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks


EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate
News | May 25, 2026

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings


Lilly brings heavy oncology firepower to ASCO with plenary data across cancers
R&D | May 25, 2026

Lilly brings heavy oncology firepower to ASCO with plenary data across cancers

The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy


Bristol Myers Squibb to unveil massive oncology data push at ASCO 2026
R&D | May 25, 2026

Bristol Myers Squibb to unveil massive oncology data push at ASCO 2026

The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”


Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment
Drug Approval | May 25, 2026

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026


Datroway wins US nod in aggressive breast cancer subtype
Drug Approval | May 25, 2026

Datroway wins US nod in aggressive breast cancer subtype

Clearance marks major shift beyond chemotherapy


AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
News | May 25, 2026

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections